AFP and hepatocellular carcinoma: In addition, we validated our results by using other cohorts (including 298 HCC patients) from the International Cancer Genome Consortium (ICGC) and unexpectedly found that the vertex and edge panels could robustly contribute to HCC prognosis (Figure 5d and e); however, it seemed that AFP lost its power in HCC prognosis (Figure 5f).